IE

Gunther Eissner

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gunther Eissner. Retrieved from https://idiyas.com/inventor/gunther-eissner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Gunther Eissner: Innovator in Vascular Endothelium Protection

Introduction

Gunther Eissner is a notable inventor based in Ireland. He has made significant contributions to the field of vascular health, particularly in protecting the vascular endothelium from immunologically mediated cytotoxic reactions. His work is crucial for individuals at risk of or afflicted with vascular inflammatory diseases.

Latest Patents

Gunther Eissner holds a patent titled "Protection Of The Vascular Endothelium From Immunologically Mediated Cytotoxic Reactions With Human Cd34-Negative Progenitor Cells." This invention provides human CD34-negative progenitor cells for use in protecting the vascular endothelium. It also includes methods for producing these progenitor cells and determining their protective abilities.

Career Highlights

Eissner is associated with Apceth GmbH & Co. KG, where he continues to advance research in his field. His innovative approaches have the potential to transform treatment options for vascular inflammatory diseases.

Collaborations

Some of his notable coworkers include Christine Guenther and Ralf Huss. Their collaborative efforts contribute to the ongoing research and development in vascular health.

Conclusion

Gunther Eissner's work in the protection of the vascular endothelium showcases his commitment to advancing medical science. His contributions are vital for improving the lives of those affected by vascular inflammatory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…